Related content

Tacrolimus (FK506) for Graft-versus-host Disease after Allogeneic Blood Stem Cell Transplantation for Hematologic Malignancies

By Gerull S.   Luft T.   Scheuer M.   Kornacker M.   Gebest H. J.   Schőnland S.   Perz J.   Ho A. D.  

The Chinese-German Journal of Clinical Oncology, Vol. 3, Iss. 1, 2004-03 ,pp. : 2-4

Springer Publishing Company

Access to resources Recommend Favorite

Recent progress in managing graft-versus-host disease and viral infections following allogeneic stem cell transplantation

By Sellar Rob S   Peggs Karl S  

Future Oncology, Vol. 8, Iss. 12, 2012-12 ,pp. : 1549-1565

Future Medicine

Access to resources Recommend Favorite

Radiation protocols determine acute graft-versus-host disease incidence after allogeneic bone marrow transplantation in murine models

By Schwarte Sebastian   Bremer Michael   Fruehauf Joerg   Sorge Yanina   Skubich Susanne   Hoffmann Matthias W.  

International Journal of Radiation Biology, Vol. 83, Iss. 9, 2007-01 ,pp. : 625-636

Informa Healthcare

Access to resources Recommend Favorite

Distinct reconstitution of neutrophil functions after allogeneic peripheral blood stem cell transplantation

By Scholl S.   Hanke M.   Höffken K.   Sayer H.  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 6, 2007-06 ,pp. : 411-415

Springer Publishing Company

Access to resources Recommend Favorite

Hyperferritinemia is associated with low incidence of graft versus host disease, high relapse rate, and impaired survival in patients with blood disorders receiving allogeneic hematopoietic stem cell grafts

By Wahlin Anders  

Medical Oncology, Vol. 28, Iss. 2, 2011-06 ,pp. : 552-558

Humana Press, Inc

Access to resources Recommend Favorite